Cross Country Healthcare, Inc. (CCRN)
NASDAQ: CCRN · IEX Real-Time Price · USD
16.52
+0.04 (0.24%)
Jul 26, 2024, 4:00 PM EDT - Market closed
Cross Country Healthcare Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year Ending | TTM | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | 2018 - 2013 |
|---|---|---|---|---|---|---|---|
| Revenue | 1,776 | 2,020 | 2,807 | 1,677 | 836.42 | 822.22 | Upgrade
|
| Revenue Growth (YoY) | -32.73% | -28.04% | 67.39% | 100.46% | 1.73% | 0.70% | Upgrade
|
| Cost of Revenue | 1,388 | 1,569 | 2,179 | 1,302 | 633.69 | 618.22 | Upgrade
|
| Gross Profit | 388.28 | 450.41 | 627.69 | 375 | 202.73 | 204.01 | Upgrade
|
| Selling, General & Admin | 290.33 | 314.95 | 334.54 | 220.04 | 176.84 | 183.97 | Upgrade
|
| Depreciation & Amortization | 18.09 | 18.35 | 12.58 | 9.85 | 9.57 | 11.18 | Upgrade
|
| Operating Expenses | 308.41 | 333.3 | 347.12 | 229.9 | 186.42 | 195.14 | Upgrade
|
| Operating Income | 79.87 | 117.11 | 280.57 | 145.1 | 16.32 | 8.87 | Upgrade
|
| Interest Expense | -4.87 | -8.09 | -14.39 | -6.87 | -2.89 | -5.31 | Upgrade
|
| Other Non Operating Income (Expenses) | 1.22 | -0 | 0.24 | 0.77 | -0.28 | -1.22 | Upgrade
|
| EBT Excluding Unusual Items | 76.22 | 109.01 | 266.41 | 139.01 | 13.15 | 2.35 | Upgrade
|
| Merger & Restructuring Charges | -3.67 | -2.55 | -1.86 | -3.73 | -6.13 | -3.77 | Upgrade
|
| Impairment of Goodwill | - | - | - | - | -10.2 | - | Upgrade
|
| Asset Writedown | -0.72 | -0.72 | -5.6 | -2.07 | -9.15 | -19.21 | Upgrade
|
| Legal Settlements | -3.65 | -1.13 | - | - | - | -1.6 | Upgrade
|
| Other Unusual Items | -1.72 | -1.72 | -2.63 | - | - | -1.98 | Upgrade
|
| Pretax Income | 66.46 | 102.89 | 256.33 | 133.21 | -12.33 | -24.21 | Upgrade
|
| Income Tax Expense | 20.58 | 30.26 | 67.86 | 1.21 | -0.19 | 31.73 | Upgrade
|
| Earnings From Continuing Operations | 45.89 | 72.63 | 188.46 | 132 | -12.14 | -55.94 | Upgrade
|
| Net Income to Company | 45.89 | 72.63 | 188.46 | 132 | -12.14 | -55.94 | Upgrade
|
| Minority Interest in Earnings | - | - | - | - | -0.82 | -1.77 | Upgrade
|
| Net Income | 45.89 | 72.63 | 188.46 | 132 | -12.96 | -57.71 | Upgrade
|
| Net Income to Common | 45.89 | 72.63 | 188.46 | 132 | -12.96 | -57.71 | Upgrade
|
| Net Income Growth | -70.57% | -61.46% | 42.77% | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | 35 | 35 | 37 | 37 | 36 | 36 | Upgrade
|
| Shares Outstanding (Diluted) | 35 | 35 | 38 | 37 | 36 | 36 | Upgrade
|
| Shares Change (YoY) | -5.91% | -5.49% | 0.39% | 3.61% | 0.76% | 0.44% | Upgrade
|
| EPS (Basic) | 1.32 | 2.07 | 5.09 | 3.60 | -0.36 | -1.61 | Upgrade
|
| EPS (Diluted) | 1.31 | 2.05 | 5.02 | 3.53 | -0.36 | -1.61 | Upgrade
|
| EPS Growth | -68.77% | -59.16% | 42.21% | - | - | - | Upgrade
|
| Free Cash Flow | 195.14 | 234.52 | 125.26 | -92.79 | 22.59 | 2.6 | Upgrade
|
| Free Cash Flow Per Share | 5.58 | 6.61 | 3.34 | -2.48 | 0.63 | 0.07 | Upgrade
|
| Gross Margin | 21.86% | 22.30% | 22.36% | 22.37% | 24.24% | 24.81% | Upgrade
|
| Operating Margin | 4.50% | 5.80% | 10.00% | 8.65% | 1.95% | 1.08% | Upgrade
|
| Profit Margin | 2.58% | 3.60% | 6.71% | 7.87% | -1.55% | -7.02% | Upgrade
|
| Free Cash Flow Margin | 10.99% | 11.61% | 4.46% | -5.53% | 2.70% | 0.32% | Upgrade
|
| EBITDA | 97.46 | 134.96 | 292.54 | 154.56 | 25.89 | 20.04 | Upgrade
|
| EBITDA Margin | 5.49% | 6.68% | 10.42% | 9.22% | 3.10% | 2.44% | Upgrade
|
| D&A For EBITDA | 17.59 | 17.85 | 11.98 | 9.45 | 9.57 | 11.18 | Upgrade
|
| EBIT | 79.87 | 117.11 | 280.57 | 145.1 | 16.32 | 8.87 | Upgrade
|
| EBIT Margin | 4.50% | 5.80% | 10.00% | 8.65% | 1.95% | 1.08% | Upgrade
|
| Effective Tax Rate | 30.96% | 29.41% | 26.48% | 0.91% | - | - | Upgrade
|
| Advertising Expenses | - | 11.5 | 16.1 | 9.5 | 6.2 | - | Upgrade
|
Source: S&P Capital IQ. Standard template.